August 2nd, 2024
12:00 PM Pacific
Register now for a special presentation on the PGN-EDODM1 program overview by the PepGen team and investigator Dr. Johanna Hamel.
Biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about PepGen.
Click here to find all our upcoming Meet the DM Drug Developers dates!
Presenters to Include
Johanna Hamel, MD
University of Rochester Medical Center
Dr. Johanna Hamel, an Assistant Professor in Neurology, Pathology, and Laboratory Medicine, developed her interest in DM1 and DM2 during medical school in Germany. Her residency at the University of Rochester, chosen for its focus on neuromuscular medicine and DM, led to a fellowship under Dr. Charles Thornton, funded by the Clinical Research Training Fellowship Award in Muscular Dystrophy. Click here to read a recent feature on Dr. Hamel by MDF!